- Introduction to HIV and AIDS
- The immune system and HIV
- Monitoring the immune system
- Genetics and HIV treatment
- Preventing HIV infection
- Ways of attacking HIV
- Starting HIV treatment
- Changing HIV treatment
- Drug resistance
- Side-effects
- Adherence
- Drug interactions and pharmacokinetics
- HIV treatment during pregnancy
- HIV treatment in children
- Treatment guidelines
- A to Z of medical tests
- Learning about medical tests
- Bilirubin
- Blood count
- Blood gases
- Bone marrow biopsy
- Brain scan
- Bronchoscopy
- Computed tomography scan (CT)
- DEXA (Dual-energy x-ray absorptiometry) scan
- Endoscopy
- Karnofsky score
- Lactate
- Lipids
- Liver function
- Lumbar puncture
- Lung function tests
- Magnetic resonance imaging (MRI)
- Nerve conduction tests
- Neurocognitive tests
- Papanicolaou (Pap) smear
- Purified protein derivative (PPD) skin tests
- Renal function tests
- Serology
- Sigmoidoscopy and rectal biopsy
- Specimen culture
- Sputum tests
- Ultrasound
- X-ray
- A to Z of drugs
- Symptoms and illnesses
A to Z of medical tests
- Learning about medical tests
- Bilirubin
- Blood count
- Blood gases
- Bone marrow biopsy
- Brain scan
- Bronchoscopy
- Computed tomography scan (CT)
- DEXA (Dual-energy x-ray absorptiometry) scan
- Endoscopy
- Karnofsky score
- Lactate
- Lipids
- Liver function
- Lumbar puncture
- Lung function tests
- Magnetic resonance imaging (MRI)
- Nerve conduction tests
- Neurocognitive tests
- Papanicolaou (Pap) smear
- Purified protein derivative (PPD) skin tests
- Renal function tests
- Serology
- Sigmoidoscopy and rectal biopsy
- Specimen culture
- Sputum tests
- Ultrasound
- X-ray
latest aidsmap news
- Slow progress to expand rountine HIV testing in the US
- Concerns over miscarriage of justice after first UK conviction for transmission of hepatitis B
- High rate of death amongst patients with HIV diagnosed late
- CD4 cell count increases sustained up to five years in developing-world treatment programmes
- Raltegravir may have role in PEP if exposure involves drug-resistant HIV
- Excellent outcomes from five years of antiretroviral use in Botswana
- Study explores verbal and non-verbal communication in unprotected sex between men
- IL-2 provides quick ‘AIDS rescue’, but effect does not always last
- Once-a-day etravirine should work as first-line treatment
- Second-line combinations fail twice as often as first-line ones in the first year